Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)
China · Delayed Price · Currency is CNY 25.81
-0.51 (-1.94%)
At close: Nov 13, 2026
SHE:301509 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 615.76 | 639.37 | 497.01 | 766.82 | 716.67 | 549.19 |
Revenue Growth | 3.05% | 28.64% | -35.19% | 7.00% | 30.50% | 18.25% |
Gross Profit Gross Profit Growth | 196.79 | 255 | 155.04 | 345.35 | 303.65 | 211.2 |
Operating Income Operating Income Growth | 25.48 | 92.64 | 7.59 | 191 | 167.39 | 92.45 |
Net Income Net Income Growth | 45.14 | 104.81 | 38.61 | 173.57 | 161.45 | 84.55 |
Earnings Per Share EPS Growth | 0.37 | 0.87 | 0.32 | 1.73 | 1.79 | 0.94 |
EPS Growth | -56.02% | 171.88% | -81.50% | -3.12% | 89.50% | 11.92% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Mainland China Mainland China Growth | 213.28 | 192.96 | 162.15 | 125.58 | 129.43 |
Other Countries and Regions Other Countries and Regions Growth | 426.1 | 304.05 | 604.67 | 591.09 | 419.76 |
Total Total Growth | 639.37 | 497.01 | 766.82 | 716.67 | 549.19 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 920.14 | 1,297 | 1,184 | 557.52 | 335.76 | 213.39 |
Total Debt Total Debt Growth | 3.47 | 3.21 | 4.76 | 11.64 | 88.07 | 75.46 |
Net Cash (Debt) Net Cash Growth | 916.67 | 1,294 | 1,179 | 545.88 | 247.69 | 137.93 |
Net Cash Growth | 57.44% | 9.71% | 116.04% | 120.39% | 79.58% | -28.23% |
Net Cash Per Share Net Cash Per Share Growth | 7.55 | 10.74 | 9.77 | 5.44 | 2.74 | 1.54 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 74.84 | 170.2 | 154.9 | 155.16 | 241.55 | 72.27 |
Capital Expenditures CapEx Growth | -92.9 | -41.84 | -54.1 | -72.9 | -126.69 | -170.66 |
Free Cash Flow Free Cash Flow Growth | -18.05 | 128.36 | 100.8 | 82.26 | 114.86 | -98.39 |
Free Cash Flow Growth | - | 27.34% | 22.54% | -28.39% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.96% | 39.88% | 31.19% | 45.04% | 42.37% | 38.46% |
Operating Margin | 4.14% | 14.49% | 1.53% | 24.91% | 23.36% | 16.83% |
Pretax Margin | 8.49% | 18.91% | 7.90% | 26.53% | 27.04% | 18.18% |
Profit Margin | 7.33% | 16.39% | 7.77% | 22.63% | 22.53% | 15.39% |
FCF Margin | -2.93% | 20.08% | 20.28% | 10.73% | 16.03% | -17.91% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.900 | 0.900 | 0.400 | 0.571 |
Dividend Per Share Growth | 125.00% | 125.00% | -30.00% | - |
Dividend Yield | 3.49% | 2.66% | 1.55% | 1.27% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 69.43 | 38.82 | 80.74 | 31.30 | - | - |
P/FCF Ratio | - | 31.70 | 30.92 | 66.04 | - | - |
PS Ratio | 5.05 | 6.36 | 6.27 | 7.08 | - | - |